Tel Aviv Sourasky Medical Center will act as the sponsor of the study PLX-PAD cells have demonstrated efficacy in preclinical models of GvHD HAIFA, Israel, Nov. 06, 2017 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced that it has signed...